Nicotine Lozenge
Product Images NDC 82966-002

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 82966-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blip Products, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Nicotine Fig1)

An instructional illustration with four color-coded circular reminders for a quit-smoking timeline: Step 1 (brown) at week 1 quit date recommends 1 lozenge every 1 to 2 hours; Step 2 (orange) at week 7 recommends 1 lozenge every 2 to 4 hours; Step 3 (teal) at week 10 recommends 1 lozenge every 4 to 8 hours; and Ex-Smoker (blue) at 12 weeks after the quit date.*

FDA Label Image

Figure2 (Nicotine Fig2)

An instructional wallet card designed to support smoking cessation, featuring a fill-in section titled 'My most important reasons to quit smoking are' with space for personal entries. Below, it lists call-for-help resources including the American Lung Association, American Cancer Society, American Heart Association, and suggests a quitting buddy or friend who has quit.*

FDA Label Image

Package Label.principal Display Panel (4 mg (27 Lozenges, Container Label))

Blip Products, Inc. Nicotine Polacrilex Lozenge 4 mg, mint flavor, mini lozenge form. The packaging is pink with black and white text, containing 27 lozenges. It is labeled as a stop smoking aid, distributed by Blip Products, Inc. in New York, made in India, and includes tamper-evident warning instructions.*

FDA Label Image

Package Label.principal Display Panel (4 mg (27 Lozenges, Container Carton Label))

The packaging label is for NICOTINE POLACRILEX MINI LOZENGE, 4 mg strength, orally administered. It is branded by BLIP PRODUCTS, INC. The label indicates 27 mint-flavored lozenges per container. The front panel highlights the nicotine polacrilex active ingredient and mint flavor with an image of mint leaves and a white lozenge. Additional panels include detailed Drug Facts, directions, warnings, and inactive ingredients. The label is predominantly pink with black and white text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.